stockrowBioventus Inc. (BVS) vs Pacific Biosciences of California, Inc. (PACB)
- Bioventus Inc. BVS 10.68 0.00%
- Pacific Biosciences of California, Inc. PACB 2.29 −5.76%
Bioventus Inc. and Pacific Biosciences of California, Inc. are both Medical Devices companies. Bioventus Inc. is the larger, with a market value of $899.9M against $755.3M — 1.2× the size. Pacific Biosciences of California, Inc. has negative trailing earnings, so its P/E is not meaningful; Bioventus Inc. trades at 12.3×. Pacific Biosciences of California, Inc. grew revenue faster over the last twelve months: 4.41% against 3.87%. Bioventus Inc. has the higher net margin (9.78% vs −81.3%) and the higher return on invested capital (7.22% vs 0.00%). Across the 18 metrics below, Bioventus Inc. leads on 12 and Pacific Biosciences of California, Inc. on 6.
Valuation
Profitability
| Metric | BVS | PACB | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.70% | 34.40% | 57.76% |
| Operating margin | 9.69% | (81.27%) | (15.07%) |
| Net margin | 9.78% | (81.31%) | (14.45%) |
| Free cash flow margin | 14.51% | (84.85%) | (3.88%) |
| Return on equity | 22.96% | 1,037.83% | (10.35%) |
| Return on assets | 8.33% | (17.22%) | (17.26%) |
| Return on invested capital | 7.22% | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack